InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. The Company is setting new therapeutic standards by enabling minimally invasive treatments that unlock the healing potential of each patient’s own regenerative cells processed at the point of care for same-day treatment. InGeneron is currently focused on helping patients impacted by orthopedic conditions and are conducting several clinical trials to validate it's technology as a disease-modifying treatment. Based on more than 20 years of research, InGeneron is dedicated to developing therapies supported by clinical evidence and approved by the FDA.